HPS Pharmacies wish to advise that Pfizer is experiencing a supply interruption for promethazine ampoules as follows:
DBL™ Promethazine Hydrochloride Ampoules
Promethazine hydrochloride 50mg/2mL
ARTG 16255
Normal supplies are expected to resume from the end of November 2026.
An internationally registered alternative has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. Please note that S19A products may have a longer lead time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Pfizer on 1800 675 229, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates